Published in Clinical Trials Week, February 4th, 2008
"The primary end point was progression-free survival; overall survival was a secondary end point. From December 2001 through May 2004, a total of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Trials Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.